-
Field_effect_of_healthy_and_diseased_livers_WGS
Study
EGAS00001002413
-
ctDNA monitoring using patient-specific sequencing and integration of variant reads - Breast cohort
Study
EGAS00001004446
-
An integrated multi-omic cellular atlas of human breast cancers
Study
EGAS00001005173
-
MutWP1__CRUK_Grand_Challenge_Mutographs_of_Cancer__Oesophageal_squamous_cell_carcinoma
Study
EGAS00001002725
-
Orphan_Tumour_Study_NB
Study
EGAS00001003445
-
Single-cell profiling of neoantigen-specific T cells in lung cancers treated with neoadjuvant PD-1 blockade
Study
EGAS00001005343
-
Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancer
Study
EGAS00001005967
-
Whole Exome sequencing of colorectal cancer patients (SG-BULK)
Study
EGAS00001006006
-
Comparison of sequencing assays for sensitive detection of circulating tumour DNA in stage IA-IV breast cancer
Study
EGAS00001006040
-
Breast cancer sequencing data
Study
EGAS00001007336
-
Understanding_the_multicellular_dynamics_of_clear_cell_renal_cell_carcinoma___visium
Study
EGAS00001006045
-
FGFR-driven urothelial cancer
Study
EGAS00001007335
-
CD8+ Tumor-Infiltrating Lymphocyte Abundance is a Positive Prognostic Indicator in Nasopharyngeal Cancer
Study
EGAS00001006396
-
DNA methylation landscape of prostate cancer
Study
EGAS00001006670
-
Integrative pan-cancer genomic and transcriptomic analyses of refractory metastatic cancer
Study
EGAS00001006648
-
Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens
Study
EGAS00001007404
-
Wilms_Tumour_organoid_sequencing_WGS
Study
EGAS00001002692
-
Bone marrow single cell genomics from blood cancer samples
Study
EGAS00001007332
-
Elucidating the molecular landscape of KRAS/BRAF mutant colorectal cancers
Study
EGAS00001007459
-
Understanding_the_multicellular_dynamics_of_clear_cell_renal_cell_carcinoma___single_cell_RNA_sequencing
Study
EGAS00001003519
-
Mutational_burden_in_skin_following_UV_treatment_Nanoseq
Study
EGAS00001007681
-
HSC_population_dynamics_KSP_samples
Study
EGAS00001002762
-
MutWP6__CRUK_Grand_Challenge_Mutographs_of_Cancer__Botseq
Study
EGAS00001004330
-
Gastric_Mutational_Signatures__GMS_
Study
EGAS00001002939
-
Gastric_Mutational_Signatures__GMS_
Study
EGAS00001002938
-
DERMATLAS__SG_basal_cell_adenoma_and_adenocarcinoma_WES
Study
EGAS00001007745
-
DERMATLAS__SG_basal_cell_adenoma_and_adenocarcinoma_RNAseq
Study
EGAS00001007746
-
Implementation of pediatric precision oncology into clinical practice: The individualized Therapies for Children with cancer program “iTHER”
Study
EGAS00001007099
-
Genomic Rearrangements in Pediatric Cancer
Study
EGAS00001005312
-
SYNTHETIC: EOSC4Cancer Study Synthetic Colorectal Cancer Genomic data
Study
EGAS50000000386
-
Nanopore_and_Illumina_sequencing_of_human_glioblastomas
Study
EGAS00001005812
-
Submission 65 - study_title 2
Study
EGAS50000000446
-
Deep single-cell RNA sequencing data for 11138 T cells from tumour, adjacent normal tissue and peripheral blood of treatment-naive CRC patients. The DATA ACCESS AGREEMENT is provided at https://github.com/zhangyybio/single-T-cell-data-access. Applicants can request access to the data by directly downloading it or by sending an email to cancerpku@pku.edu.cn. The process that is used to approve an application includes verifying the institution, participants and research purposes of the application. In general this process will take about two weeks. In principal, any scientific research program complying with the laws and bioethic regulation policies of China will be approved.
Study
EGAS00001002791
-
Canadian prostate cancer samples (CPC-GENE) for PanProstate study
Study
EGAS00001003037
-
Genomic analysis of high-risk prostate cancer.
Study
EGAS00001003088
-
German early-onset prostate cancer cohort of the Pan-Prostate Cancer Genome (PPCG) project
Study
EGAS00001003373
-
Clinical outcomes in ctDNA-positive urothelial carcinoma patients treated with adjuvant immunotherapy
Study
EGAS00001004997
-
an integrated molecular study of clear cell renal cell carcinoma (ccRCC) including whole-genome/exome and RNA sequencing as well as array-based gene expression/copy-number/methylation analyses
Study
EGAS00001000509
-
Targeted_sequencing_of_genes_recurrently_mutated_in_AML___part2
Study
EGAS00001000570
-
The Medical Genome Reference Bank: a whole genome data resource of 4,000 healthy elderly individuals.
Study
EGAS00001003511
-
Dynamics of genomic clones in breast cancer patient xenografts at single cell resolution
Study
EGAS00001000952
-
Breast cancer miRNAs
Study
EGAS50000000461
-
CZ_END-2-END_final
Dataset
EGAD50000000475
-
DERMATLAS__Leiomyosarcoma_WES
Study
EGAS00001007628
-
DERMATLAS__Leiomyosarcoma_RNAseq
Study
EGAS00001007631
-
RNA-Sequencing data of patient derived normal fibroblasts (NFs), cancer associated fibroblasts (CAFs) and tumor spheroid samples
Study
EGAS00001007205
-
CZ_TEST3_END-2-END
Dataset
EGAD50000000473
-
Deep whole genome ctDNA chronology of treatment-resistant prostate cancer
Study
EGAS00001005783
-
Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma
Study
EGAS00001001653
-
Tumor microenvironment study of ovarian granulosa cell tumors
Study
EGAS00001006478